Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
Kumar P, Johnson M, Molina JM, Rizzardini G, Cahn P, Bickel M, Wan H, Xu ZJ, Morais C, Sklar P, Greaves W; DRIVE-SHIFT Study Group. Kumar P, et al. Among authors: morais c. J Acquir Immune Defic Syndr. 2021 Jun 1;87(2):801-805. doi: 10.1097/QAI.0000000000002642. J Acquir Immune Defic Syndr. 2021. PMID: 33633036 Free PMC article. Clinical Trial.
Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.
Johnson M, Kumar P, Molina JM, Rizzardini G, Cahn P, Bickel M, Mallolas J, Zhou Y, Morais C, Kumar S, Sklar P, Hanna GJ, Hwang C, Greaves W; DRIVE-SHIFT Study Group. Johnson M, et al. Among authors: morais c. J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):463-472. doi: 10.1097/QAI.0000000000002056. J Acquir Immune Defic Syndr. 2019. PMID: 30985556 Free PMC article. Clinical Trial.
Severe Central Nervous System Histoplasmosis in an Immunocompetent Child.
Almeida FJ, de Morais CO, Almeida Farias CG, Gomes Cavalcante DT, de Matos SF, Prado da Silva DGB, Jarovsky D, Sáfadi MAP. Almeida FJ, et al. Among authors: de morais co. Pediatr Infect Dis J. 2024 Dec 17. doi: 10.1097/INF.0000000000004690. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 39705602 No abstract available.
Dengue: a hidden threat in blood transfusions amidst Brazil's largest outbreak?
Almeida FJ, Pacheco JT, Farias CGA, de Matos SF, de Morais CO, Guerra GG, Dos Santos ACC, Jarovsky D, Bezerra RF, Furlanetto BHS, Oliveira DBL, Sáfadi MAP. Almeida FJ, et al. Among authors: de morais co. Lancet Infect Dis. 2025 Jan;25(1):e10. doi: 10.1016/S1473-3099(24)00795-3. Epub 2024 Nov 29. Lancet Infect Dis. 2025. PMID: 39622264 No abstract available.
Expansion of Oropouche virus in non-endemic Brazilian regions: analysis of genomic characterisation and ecological drivers.
Gräf T, Delatorre E, do Nascimento Ferreira C, Rossi A, Santos HGG, Pizzato BR, Nascimento V, Souza V, de Lima GB, Dezordi FZ, da Silva AF, de Morais CNL, Arantes I, Machado MH, Rovaris DB, Presibella MM, Marques NFQ, Pouzato EG, Stadinicki J, Ribeiro-Rodrigues R, de Jesus Sousa T, Cavalcanti AC, Camargo AC, E Silva KMP, de Oliveira Marques da Costa MM, de Bruycker-Nogueira F, Zanluca C, de Filippis AMB, Dos Santos CND, Wallau GL, Bello G, Naveca FG; OROV Study Group. Gräf T, et al. Among authors: de morais cnl. Lancet Infect Dis. 2024 Nov 15:S1473-3099(24)00687-X. doi: 10.1016/S1473-3099(24)00687-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39557055
Pairing phase favored by magnetic frustration.
Krindges A, Morais CV, Schmidt M, Zimmer FM. Krindges A, et al. Among authors: morais cv. J Phys Condens Matter. 2024 Dec 4;37(7). doi: 10.1088/1361-648X/ad922b. J Phys Condens Matter. 2024. PMID: 39536708
602 results